VerAvanti Inc. is a medical device company working on development of an optical imaging technology that, when productized, could offers the potential for interventional cardiologists to reduce sight line gaps that are critical to proactively diagnosing and treating individuals at-risk for stroke and cardiovascular events. With the objectives of improving clinical outcome and lowering the overall cost of healthcare, the patented medical device is called a Scanning Fiber Endoscope.
